ADAM17 and familial dilated cardiomyopathy: To test this hypothesis, we investigated the mechanism through which ADAM17 knockout combined with eplerenone therapy ameliorates left ventricular remodeling and function in a mouse model of DCM in vivo and whether ADAM17 knockout combined with eplerenone treatment reduces CMT in rat cardiac fibroblasts in vitro.